Navigation Links
New Director of Lab Sales for Polymathic Analytical Labs
Date:8/4/2009

ORANGEBURG, S.C., Aug. 4 /PRNewswire/ -- Polymathic Analytical Labs, a Zeus company, announces that William J. Kerr will assume the role of Director of Laboratory Sales. With more than 40 years of polymer experience, Polymathic Analytical Labs' core business is the specialized and routine testing of biomaterials, thermoplastics and thermosets. As Director of Laboratory Sales, Kerr is tasked with developing and implementing a comprehensive sales and marketing strategy to expand the laboratory's presence in the plastics industry.

Kerr is a technical sales professional who previously worked as a regional sales manager for a distributor of plastic raw materials. He has a wealth of experience and success in defining market strategies, achieving sales growth and providing sales leadership.

"We are pleased Bill has joined our team and impressed with his more than 24 years in sales leadership within competitive markets," said Chris Given, Laboratory Manager. "With Bill's expertise and proven track record, we will be better able to assess the needs of our partners, meet customer demands and maintain lasting business relationships."

Kerr is a graduate of the University of Pittsburgh with a B.A. in Business Administration and Political Science, along with a double minor in Chemistry and Mathematics. He speaks both German and Spanish as second languages. Kerr officially joined Polymathic Analytical Labs on July 22, 2009.

Staffed by analytical and polymer science professionals, Polymathic Analytical Labs provides dependable polymer testing services for identification of materials, polymer characterization and qualification. Our testing capabilities include, FT-IR Spectroscopy, Thermogravimetric Analysis, analysis of electrical and mechanical properties and characterization of a wide range of polymeric materials for QA/QC purposes. For more information, visit

SOURCE Polymathic Analytical Labs
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. PDI Appoints Gerald P. Belle as Lead Independent Director
2. Atherotech Taps Canyons Medical Center Director, Lipidologist as Chief Medical Officer
3. Marinus Pharmaceuticals Adds Two Life Sciences Veterans to its Board of Directors
4. Signostics Closes Follow-On Financing of US$4 Million, Expands Board of Directors
5. Poniard Pharmaceuticals Appoints Gary A. Lyons to Board of Directors
6. IDEV Technologies Names Veteran Medical Device Executive Rick Anderson Chairman of the Board of Directors
7. GeoVax Labs, Inc. Announces Resignation of Director
8. Biocept, Inc. Announces Two New Director Appointments
9. Former Secretary of Veterans Affairs James Peake to Join the Cellphire Board of Directors
10. Rib-X Pharmaceuticals, Inc. Appoints Dr. Russell Greig to Board of Directors
11. Nobel Laureate Lee Hartwell to Retire as President and Director of Fred Hutchinson Cancer Research Center in 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 A study has been ... the Formula 1 track could help to tackle the problem ... (MAT), Stowhealth (a GP surgery based in Stowmarket) and academics ... Simplyhealth. Telemetry technology, which is inspired by equipment ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 The Microcompetition with ... major disease. One of these latent viruses is the Epstein ... arthritis (RA). Rheumatoid arthritis (RA) is a chronic inflammatory disease ... a study found that RA patients have high concentrations of ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... throughput research solutions, today announced that Lupin Limited, one ... of Freeslate’s CM Protégé PharmD System for ... in Mumbai, India, is focused on a wide range ...
(Date:1/14/2014)... Date: Friday, April 11, 2014 , Time: ... 1360 Almshouse Road, Warrington, Pa. , Details: The ... to finding a cure for hepatitis B and improving the ... annual Crystal Ball on Friday, April 11 at Warrington Country ...
Breaking Biology Technology:Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2
... Six Years Recognizes Breakthrough ... Form of Heart Disease, ABBOTT PARK, Ill., Oct. ... Chicago Innovation Award for its XIENCE V(TM),Everolimus Eluting Coronary ... clinical data, the next-generation drug eluting stent,represents a significant ...
... CAMBRIDGE, Mass., Oct. 28 Peptimmune, Inc., a privately,held biotechnology ... provide an update on the Company,s current phase Ib clinical,trial ... 1. BIO Investor Forum 2008. The presentation will ... at 3:15 p.m. in the Pacific Room at the Palace ...
... DIEGO, Oct. 28 Volcano Corporation,(Nasdaq: VOLC ), ... for the diagnosis and treatment of coronary and peripheral ... results for the,third quarter and first nine months of ... hold a conference call to discuss its financial,results and ...
Cached Biology Technology:Abbott's XIENCE V(TM) Drug Eluting Stent Wins Prestigious Chicago Innovation Award 2Abbott's XIENCE V(TM) Drug Eluting Stent Wins Prestigious Chicago Innovation Award 3Peptimmune Presentations at Upcoming Events 2Volcano Corporation Schedules Third Quarter Conference Call, Webcast 2
(Date:4/23/2014)... in their mid-thirties and forties, face a devastating ... two decades. "Mutant" protein clusters, long blamed for ... the primary focus of therapies in development by ... Prof. Gerardo Lederkremer and Dr. Julia Leitman of ... Immunology, in collaboration with Prof. Ulrich Hartl of ...
(Date:4/23/2014)... Putnam Valley, NY. (Apr. 23 2014) ... human neural stem cells (hNSCs) into the brains ... differentiation after 22 and 24 months found that ... months and did not cause tumors. , The ... of Cell Transplantation but is currently ...
(Date:4/23/2014)... likelihood of an accurate group decision increases with the ... a collective faces a variety of factors as ... researchers report that smaller groups actually tend to make ... focused on only certain pieces of information. , The ... about collective intelligence, or the "wisdom of crowds," wherein ...
Breaking Biology News(10 mins):On the defensive 2On the defensive 3Study finds long-term survival of human neural stem cells transplanted into primate brain 2Too many chefs: Smaller groups exhibit more accurate decision-making 2Too many chefs: Smaller groups exhibit more accurate decision-making 3
... common, but few studies of lung nodule identification and ... from Kaiser Permanente Southern California identified 7,112 patients who ... within the electronic medical record. Their study ... Association for the Study of Lung Cancer,s (IASLC) ...
... WORCESTER, Mass. A new genetic mutation that causes ... also known as Lou Gehrig,s Disease, has been identified ... the University of Massachusetts Medical School (UMMS). Mutations to ... growth and development of nerve cell axons, is estimated ...
... new study by University of North Carolina School of Medicine ... risk for autism spectrum disorders (ASD) at 12 months received ... In addition, 85 percent of the children found to be ... Year Inventory (FYI), a 63-item questionnaire filled out by their ...
Cached Biology News:UMMS researchers isolate gene mutations in patients with inherited amyotrophic lateral sclerosis 2UMMS researchers isolate gene mutations in patients with inherited amyotrophic lateral sclerosis 3Questionnaire completed by parents may help identify 1-year-olds at risk for autism 2
... X-Gal ,MOLECULAR BIOLOGY GRADE ,5-Bromo-4-chloro-3-indoxyl-beta-D-galactopyranoside C ... Cl N O 6 ,M.W.= ... ,Solution: Clear (2% in DMF) ,Biological ... and M13 ,Elemental Analysis: Agrees with ...
...
Antibodies were affinity purified using epitopes specific to RFC1 immobilized on solid support....
prototype Nco I...
Biology Products: